{ "items": [ "\n\n
\n \n 19 September 2023\n \n
\n\n \n\n \n \n \n\u2018I\u2019m a Scientist\u2019 is a student-led STEM enrichment activity, which connects school students with scientists through energetic, real-time text-based chats.
\n \n\n\n \n 11 September 2023\n \n
\n\n \n\n \n \n \nA study led by the Mead Group has demonstrated a previously unknown effect of chronic inflammation on TP53-mutant blood stem cells, shedding light on the progression of leukaemia.
\n \n\n\n \n 5 September 2023\n \n
\n\n \n\n \n \n \nOxford Cancer will host workshop on patient priorities for those with HCC (hepato-cellular carcinoma).
\n \n\n\n \n 24 August 2023\n \n
\n\n \n\n \n \n \nA team of researchers led by the Nuffield Department of Primary Care Health Sciences, have developed a new model that reliably predicts a woman's likelihood of developing and then dying of breast cancer within a decade.
\n \n\n\n \n 22 August 2023\n \n
\n\n \n\n \n \n \nThe CRUK Oxford Centre - Oxford Cancer Symposium is the crowning event in the Oxford Cancer calendar. With approximately 300 people attending in person each year, it provides an opportunity for our members to network and build new collaborations.
\n \n\n\n \n 21 August 2023\n \n
\n\n \n\n \n \n \nBlood Cancer UK and Cancer Research UK recognise the need and impact of artificial intelligence approaches developed by Professor Daniel Royston and Professor Jens Rittscher for early detection and assessment of blood cancers.
\n \n\n\n \n 21 August 2023\n \n
\n\n \n\n \n \n \nIn a pan-cancer analysis spanning 24 different cancer types, researchers shed light on the relationship between SETD2, DNA methylation and cancer development.
\n \n\n\n \n 18 August 2023\n \n
\n\n \n\n \n \n \nRichard White has received the 2023 Outstanding Research award from the Society for Melanoma Research.
\n \n\n\n \n 15 August 2023\n \n
\n\n \n\n \n \n \nA new study from Professor Julia Hippisley-Cox and colleagues offers hope for the earlier detection of oesophageal cancer.
\n \n\n\n \n 7 August 2023\n \n
\n\n \n\n \n \n \nThe National Institute for Health and Care Research (NIHR) has announced a major investment in its Policy Research Units (PRUs). Researchers in the Nuffield Department of Primary Care Health Sciences at Oxford will play a key role in a new Unit focusing on the early detection of cancer.
\n \n\n\n \n 25 July 2023\n \n
\n\n \n\n \n \n \nResearch led by the Nuffield Department of Medicine has been published in Nature Scientific Reports, investing the effect of COVID-19 across the cancer population over the course of the pandemic. This analysis is the world\u2019s largest and most comprehensive cancer evaluation showcasing the United Kingdom\u2019s digital capabilities and the potential of population-scale cancer studies.
\n \n\n\n \n 20 July 2023\n \n
\n\n \n\n \n \n \nNew research, led by Professor Anindita Roy, is to be funded by families affected by childhood cancer through Children\u2019s Cancer and Leukaemia Group (CCLG)'s Special Named Fund programme.
\n \n\n\n \n 17 July 2023\n \n
\n\n \n\n \n \n \nOxford researchers have been given a \u00a31 million boost to support their strategy of developing cancer prevention treatments and early diagnostic tools for people at high risk of cancer.
\n \n\n\n \n 12 July 2023\n \n
\n\n \n\n \n \n \nA new research project, led by Dr Toral Gathani and funded by Cancer Research UK, aims to shed light on the variation in breast cancer in different ethnic minority groups.
\n \n\n\n \n 11 July 2023\n \n
\n\n \n\n \n \n \nA team of Oxford researchers has discovered a link between immune cells known as monocytes in tumours and overall survival in patients with oesophageal cancer.
\n \n\n\n \n 4 July 2023\n \n
\n\n \n\n \n \n \nWe were delighted to officially launch our Oxford Cancer Immuno-Oncology Network on the 23rd of June, with over 100 people in attendance and the luxury of convening at the Ashmolean Museum.
\n \n\n\n \n 30 June 2023\n \n
\n\n \n\n \n \n \nNew research led by Dr Johanna Michl and Professor Pawel Swietach has solved the longstanding mystery of how cancer cells are able to maintain a relatively alkaline intracellular pH, despite being surrounded by an acidic environment.
\n \n\n\n \n 15 June 2023\n \n
\n\n \n\n \n \n \nDavid Hunter, Richard Doll Professor of Epidemiology and Medicine at Oxford Population Health, has been appointed as a Companion of the Order of Australia in the Australian King\u2019s Birthday Honours List.
\n \n\n\n \n 14 June 2023\n \n
\n\n \n\n \n \n \nA study conducted by researchers at Oxford Population Health has found that women who are diagnosed with early stage breast cancer today are 66% less likely to die from the disease within five years of diagnosis than they were 20 years ago.
\n \n\n\n \n 13 June 2023\n \n
\n\n \n\n \n \n \nResearchers from Oxford's Ludwig Institute for Cancer Research and de Duve Institute have found out that drugs used to treat hypertension could substantially improve the clinical efficacy of cancer immunotherapy. They discovered a new treatment approach that helps T lymphocytes to destroy cancerous cells.
\n \n\n